CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte®

/PRNewswire/ -- CellResearch Corporation, a Singapore-based biopharmaceutical company today announced it has successfully closed the first Phase I study in...

Related Keywords

Colorado ,United States ,Singapore ,Xavier Simpson ,Cellresearch Corporation ,University Of Colorado ,Menarini Group ,Cellresearch Consumer Health ,Business Development ,Anschutz Medical Campus ,Clinimmune Cell ,Cecilia Low Wang ,Anschutz Medical ,Research Corporation ,Research Consumer Health ,South East ,Investor Relations ,